BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38815201)

  • 1. Deprescribing: An umbrella review.
    Japelj N; Horvat N; Knez L; Kos M
    Acta Pharm; 2024 Jun; 74(2):249-267. PubMed ID: 38815201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
    Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
    J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of deprescribing in older adults with dementia: a narrative review.
    Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
    [No Abstract]   [Full Text] [Related]  

  • 6. Deprescribing interventions in older adults: An overview of systematic reviews.
    Chua S; Todd A; Reeve E; Smith SM; Fox J; Elsisi Z; Hughes S; Husband A; Langford A; Merriman N; Harris JR; Devine B; Gray SL;
    PLoS One; 2024; 19(6):e0305215. PubMed ID: 38885276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
    Chou J; Tong M; Brandt NJ
    J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy.
    Omuya H; Nickel C; Wilson P; Chewning B
    Int J Pharm Pract; 2023 Jun; 31(4):349-368. PubMed ID: 37155330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences.
    Bondurant-David K; Dang S; Levy S; Sperlea D; Vanier MC; Gerardi S; David PM
    Int J Pharm Pract; 2020 Dec; 28(6):635-642. PubMed ID: 33094884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review.
    Ulley J; Harrop D; Ali A; Alton S; Fowler Davis S
    BMC Geriatr; 2019 Jan; 19(1):15. PubMed ID: 30658576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
    Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
    Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for outcome measurement for deprescribing intervention studies.
    Bayliss EA; Albers K; Gleason K; Pieper LE; Boyd CM; Campbell NL; Ensrud KE; Gray SL; Linsky AM; Mangin D; Min L; Rich MW; Steinman MA; Turner J; Vasilevskis EE; Dublin S
    J Am Geriatr Soc; 2022 Sep; 70(9):2487-2497. PubMed ID: 35648465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the evidence for deprescribing interventions among older people living with frailty.
    Ibrahim K; Cox NJ; Stevenson JM; Lim S; Fraser SDS; Roberts HC
    BMC Geriatr; 2021 Apr; 21(1):258. PubMed ID: 33865310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validated medication deprescribing instruments for patients with palliative care needs palliative care: A systematic review.
    de Andrade FK; Ignacio Nunes RP; Barboza Zanetti MO; Barboza Zanetti AC; Dos Santos M; de Oliveira AM; Carson-Stevens A; Leira Pereira LR; Rossi Varallo F
    Farm Hosp; 2024; 48(2):T83-T89. PubMed ID: 38016841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validated medication deprescribing instruments for patients with palliative care needs: a systematic review.
    de Andrade FK; Nunes RPI; Zanetti MOB; Zanetti ACB; Dos Santos M; de Oliveira AM; Carson-Stevens A; Pereira LRL; Varallo FR
    Farm Hosp; 2024; 48(2):83-89. PubMed ID: 37770284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MEDICATIONS DEPRESCRIBING IN ELDERLY NURSING HOME RESIDENTS].
    Aizen E; Hindawil E; Hijazi M; Merih A; Shahla H; Elyounes AA
    Harefuah; 2016 Mar; 155(3):145-9, 197. PubMed ID: 27305746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Prescribing: Polypharmacy and Deprescribing.
    McQuade BM; Campbell A
    FP Essent; 2021 Sep; 508():33-40. PubMed ID: 34491710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting systematic reviews on deprescribing trials to better inform future practice and research.
    Spinewine A; Reeve E; Thompson W
    Br J Clin Pharmacol; 2023 Dec; 89(12):3758-3764. PubMed ID: 37522371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of deprescribing on health outcomes: An umbrella review of systematic reviews with meta-analysis of randomized controlled trials.
    Veronese N; Gallo U; Boccardi V; Demurtas J; Michielon A; Taci X; Zanchetta G; Campbell Davis SE; Chiumente M; Venturini F; Pilotto A
    Ageing Res Rev; 2024 Mar; 95():102237. PubMed ID: 38367812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.